Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day
Complete. Here is the key summaryBristol Myers Squibb Co. (BMY) shares rose 3.30% to $59.52 on a challenging trading day for the market, with the S&P 500 and Dow Jones falling 1.23% and 1.20%, respectively. This marks the fifth consecutive day of gains for BMY, which is currently 6.02% below its 52-week high of $63.33. The stock outperformed competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories. Trading volume reached 23.9 million, surpassing the 50-day average of 14.6 million.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) advanced 3.30% to $59.52 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.23% to 6,798.40 and Dow Jones Industrial Average falling 1.20% to 48,908.72.
This was the stock's fifth consecutive day of gains.
Bristol Myers Squibb Co. closed 6.02% below its 52-week high of $63.33, which the company achieved on March 11th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 1.42% to $237.79, Pfizer Inc. (PFE) fell 1.08% to $26.49, and Abbott Laboratories (ABT) rose 0.81% to $109.08.
Trading volume (23.9 M) eclipsed its 50-day average volume of 14.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 5, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
02-05-26 1639ET